drugset
Drugs / Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)
last change Mar 2022 re-read 3 minutes ago

Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)

Cell therapy

Developed for
osteoarthritis, knee
Investigated by
Cytopeutics Sdn. Bhd. · Universiti Kebangsaan Malaysia Medical Centre

Trials 1

today NCT05016011 · Ph 2
202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT05016011 Jul 2020 → Mar 2022 osteoarthritis, knee Cytopeutics Sdn. Bhd. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) ClinicalTrials.gov intervention name — accepted as the source's own label NCT05016011 ↗
Modality Cell therapy “Human umbilical cord-derived mesenchymal stem cells” NCT05016011 ↗